4893.T
Price:
$161
Market Cap:
$6.97B
Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.
Industry
Biotechnology
IPO Date
2023-06-28
Stock Exchange
JPX
Ticker
4893.T
According to Noile-Immune Biotech Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 69.34. This represents a change of 3.54% compared to the average of 66.97 of the last 4 quarters.
The mean historical Current Ratio of Noile-Immune Biotech Inc. over the last ten years is 47.77. The current 69.34 Current Ratio has changed 14.42% with respect to the historical average. Over the past ten years (40 quarters), 4893.T's Current Ratio was at its highest in in the September 2024 quarter at 79.74. The Current Ratio was at its lowest in in the December 2022 quarter at 13.68.
Average
47.77
Median
52.50
Minimum
13.68
Maximum
68.77
Discovering the peaks and valleys of Noile-Immune Biotech Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 384.60%
Maximum Annual Current Ratio = 68.77
Minimum Annual Increase = -73.95%
Minimum Annual Current Ratio = 13.68
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 68.77 | 3.76% |
| 2023 | 66.28 | 384.60% |
| 2022 | 13.68 | -73.95% |
| 2021 | 52.50 | 39.49% |
The current Current Ratio of Noile-Immune Biotech Inc. (4893.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
49.57
5-year avg
47.77
10-year avg
47.77
Noile-Immune Biotech Inc.’s Current Ratio is greater than TMS Co., Ltd. (26.11), greater than K Pharma,Inc. (19.41), greater than BrightPath Biotherapeutics Co., Ltd. (12.43), greater than OncoTherapy Science, Inc. (4.06), greater than ADR120S, Inc. (5.44), greater than Linical Co., Ltd. (1.55), greater than PRISM BioLab Co.,LTD (4.64), greater than MedRx Co., Ltd (28.01), greater than Chiome Bioscience Inc. (4.72), greater than Kohjin Bio Co., Ltd. (1.83),
| Company | Current Ratio | Market cap |
|---|---|---|
| 26.11 | $6.10B | |
| 19.41 | $7.43B | |
| 12.43 | $4.63B | |
| 4.06 | $7.11B | |
| 5.44 | $7.44B | |
| 1.55 | $6.82B | |
| 4.64 | $6.51B | |
| 28.01 | $6.53B | |
| 4.72 | $7.55B | |
| 1.83 | $7.96B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Noile-Immune Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Noile-Immune Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Noile-Immune Biotech Inc.'s Current Ratio?
How is the Current Ratio calculated for Noile-Immune Biotech Inc. (4893.T)?
What is the highest Current Ratio for Noile-Immune Biotech Inc. (4893.T)?
What is the 3-year average Current Ratio for Noile-Immune Biotech Inc. (4893.T)?
What is the 5-year average Current Ratio for Noile-Immune Biotech Inc. (4893.T)?
How does the current Current Ratio for Noile-Immune Biotech Inc. (4893.T) compare to its historical average?